nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cardiovascular effects of tadalafil
|
Kloner, Robert A |
|
2003 |
92 |
9S1 |
p. 37-46 10 p. |
artikel |
2 |
Cardiovascular effects of tadalafil in patients on common antihypertensive therapies
|
Kloner, Robert A |
|
2003 |
92 |
9S1 |
p. 47-57 11 p. |
artikel |
3 |
Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction
|
Padma-Nathan, Harin |
|
2003 |
92 |
9S1 |
p. 19-25 7 p. |
artikel |
4 |
Introduction: erectile dysfunction and cardiovascular risk factors
|
Kloner, Robert A. |
|
2003 |
92 |
9S1 |
p. 1-2 2 p. |
artikel |
5 |
Overview of phosphodiesterase 5 inhibition in erectile dysfunction
|
Rosen, Raymond C |
|
2003 |
92 |
9S1 |
p. 9-18 10 p. |
artikel |
6 |
Roundtable discussion: tadalafil study group
|
Kloner, Robert A |
|
2003 |
92 |
9S1 |
p. 58-65 8 p. |
artikel |
7 |
Sexual activity and cardiovascular disease
|
Cheitlin, Melvin D |
|
2003 |
92 |
9S1 |
p. 3-8 6 p. |
artikel |
8 |
Sildenafil in patients with cardiovascular disease
|
Brindis, Ralph G |
|
2003 |
92 |
9S1 |
p. 26-36 11 p. |
artikel |